Ni Lu

<scp>First-in-Human</scp> Phase I Study of Envafolimab, a Novel Subcutaneous <scp>Single-Domain Anti-PD-L1</scp> Antibody, in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Wael A. Harb, Cody J. Peer et al. · The Oncologist · 2021 · 75 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Exercise intensity-dependent reverse and adverse remodeling of voltage-gated Ca2+ channels in mesenteric arteries from spontaneously hypertensive rats

Yu Chen, Hanmeng Zhang, Yanyan Zhang et al. · Hypertension Research · 2015 · 29 citations · Full text

Life Sciences, Biophysics, Physiology +17

Chronic exercise normalizes changes in <scp><scp>Ca</scp></scp>_v1.2 and <scp><scp>K_Ca</scp></scp>1.1 channels in mesenteric arteries from spontaneously hypertensive rats

Lijun Shi, Hanmeng Zhang, Yu Chen et al. · British Journal of Pharmacology · 2014 · 25 citations · Full text

Life Sciences, Cardiology, Physiology +17

Exercise Training Reverses Alterations in K&lt;sub&gt;v&lt;/sub&gt; and BK&lt;sub&gt;Ca&lt;/sub&gt; Channel Molecular Expression in Thoracic Aorta Smooth Muscle Cells from Spontaneously Hypertensive Rats

Zhencheng Li, Ni Lu, Lijun Shi · Journal of Vascular Research · 2014 · 21 citations

Life Sciences, Cardiology, Physiology +17

Phase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA

K. Papadopoulos, Wael A. Harb, Ni Lu et al. · Annals of Oncology · 2018 · 15 citations · Full text

Medicine, Immunology, Oncology +14